Abstract
A localized left breast ductal invasive triple-negative breast carcinoma (TNBC) was diagnosed in a 44-year-old woman. After surgery, she was treated with chemotherapy and radiation therapy in accordance with national guidelines. At the end of treatment, she had local and metastatic relapse with multiple sub-diaphragmatic lymph nodes.
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Animals
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cetuximab
-
Cisplatin / therapeutic use
-
Cyclophosphamide / therapeutic use
-
Docetaxel
-
Epirubicin / therapeutic use
-
Female
-
Humans
-
Mammary Neoplasms, Animal / drug therapy*
-
Mice
-
Neoplasm Metastasis / drug therapy*
-
Neoplasm Metastasis / genetics
-
Neoplasm Transplantation
-
Paclitaxel / therapeutic use
-
Taxoids / therapeutic use
-
Transplantation, Heterologous
-
Treatment Outcome
-
Triple Negative Breast Neoplasms / genetics
-
Triple Negative Breast Neoplasms / therapy*
Substances
-
Antibodies, Monoclonal, Humanized
-
Taxoids
-
Docetaxel
-
Epirubicin
-
Cyclophosphamide
-
Paclitaxel
-
Cetuximab
-
Cisplatin